

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
A case report of a 22-year-old man with a history of sarcoidosis who presented with possible hepatosplenomegaly. The authors used liver/spleen scintigraphy to evaluate the patient's liver function and diagnose portal hypertension. The causes, symptoms, and diagnostic methods of portal hypertension and hepatosplenomegaly, as well as the potential complications and management strategies.
What you will learn
Typology: Study notes
1 / 3
This page cannot be seen from the preview
Don't miss anything!
Robin A. Greene
Yale University Medical Center/Yale New Haven Hospital, New Haven, Connecticut
The liver is vulnerable to a host of disease processes, includ- ing portal hypertension. This is a severe hepatic condition in which the liver is subject to numerous imbalances: increased hepatic blood flow, increased portal vein pressure due to extra- hepatic portal vein obstruction, and/or increases in hepatic blood flow resistance (J). Although many disease states may be responsible for the development of portal hypertension, it is most commonly associated with moderately severe or ad- vanced cirrhosis (2). Advanced, untreated portal hypertension may cause additional complications such as hepatosplenomeg- aly, gastrointestinal bleeding, and ascites {1).
The patient was a 22-yr-old man with a long history of sar- coidosis, a chronic granulomatous disease process of unknown etiology. Sarcoidosis is characterized by the formation of tubercle-like lesions in affected organs, usually the skin, lymph nodes, lungs, and bone marrow (3). This patient had confirmed pulmonary, eye, and dermatologic involvement. Because of persistent elevation in liver function tests, the clinicians be- lieved that sarcoid involvement of the liver was present as well. An abdominal exam revealed possible hepatosplenomegaly, and a liver/spleen scan was requested. After the intravenous administration of 6 mCi (222 MBq of technetium-99m (^99 mTc) sulfur colloid, multiple planar images of the liver and spleen were obtained with a scintillation camera. The images were collected for 750,000 counts each, employing a 20% window that was centered on the 140 keY photopeak of 99 mTc. High resolution collimation was used. Image evaluation (Fig. 1) revealed that both the liver and spleen were enlarged (the spleen measured 23 em in its longest dimension). No focal defects were apparent in the images. There was minimal shift of radiocolloid from the liver to the spleen. The patient did not agree to a liver biopsy so there was no confirmed diagnosis, although infectious hepatitis was suspected based on all of the other tests performed.
In normal persons, the distribution ratio of 99 mTc radio- colloid between the liver and spleen is about 5.5:1. In the presence of portal hypertension this ratio decreases or may
For reprints contact: Robin A. Greene, Yale University School of Medicine, TIMI Core Lab, Fitkin 2, Room 206, 333 Cedar Street, New Haven, Cf 06504.
VOLUME 15, NUMBER 4, DECEMBER 1987
be reversed in more severe cases (2). This individual's 99 mTc sulfur colloid images demonstrated the combination of an enlarged liver and spleen, with homogeneous distribution of radiocolloid. A slight shift in activity to the spleen was also noted. The clinician's diagnosis based on these findings sug- gested diffuse hepatocellular disease. The confirmation of this diagnosis will require subsequent testing for other processes such as infectious hepatitis, which has been found to produce
TABLE 1. Causes of Hepatosplenomegaly
Common Metastatic tumors Fatty infiltration Hepatitis Cirrhosis Congestive heart failure Abscess Leukemia Lymphoma Normal variants-Reidel's lobe
Uncommon Infection Tuberculosis Infectious mononucleosis Hemochromatosis Chronic passive congestion Trauma Hemolysis Erythroblastosis fetalis Chronic hemolytic anemia Drugs Phenobarbital Diphenylhydantoin Sulfonamides Acetaminophen Tetracycline Corticosteroids Methotrexate Androgens Primary tumors Cysts (hydatid)
Rare Inherited metabolic disorders with hepatic involvement Wolman's disease Glycogen storage disease
Rare (continued) Wilson's disease Gaucher's disease M ucopolysaccharidosis Niemann-Pick disease Gangliosidosis Alpha 1-antitrypsin deficiency Hepatic porphyrias Cystic fibrosis Histiocytosis X Galactosemia Acromegaly Polycystic disease Inflammatory noninfective disorders Sarcoidosis Granulomatous hepatitis Juvenile rheumatoid arthritis Kwashiorkor Biliary obstruction Amyloidosis Vascular disorders Hereditary hemorrhagic telangiectasia Multinodular hemangiomatosis Cavernous hemangiomas Budd-Chiari syndrome Jamaican vomiting disease Infection Congenital or postnatal syphilis Schistosomiasis Amebiasis Actinomycosis Hydatid cyst Weil's disease Proxysmal nocturnal hemoglobinuria
similar scintigraphic appearances. Infiltrative processes such as sarcoidosis, leukemia, or intrahepatic lymphoma (4) may demonstrate hepatosplenomegaly, but there is less intense uptake of the colloid in the spleen. Additional testing to aid in differential diagnosis may include abdominal radiographic evaluation in an attempt to visualize calcification of the portal vein to confirm or evaluate the extent of the hepatosplenomegaly (1). Computed tomography and ultrasound scanning may also be employed. Clinicians should use a combined approach in the diagnosis and management of these patient because of the many disease states in which hepatosplenomegaly may be present (Table 1) (4).
Patients with portal hypertension are hospitalized and moni- tored for some of the complications that may accompany the disease state. Should the patient present with acute upper gastrointestinal bleeding, blood transfusions may be clinically indicated. A hospitalized patient may receive the specialized management available for the various complications that may accompany portal hypertension. Accurate diagnosis is essential to provide the clinician with appropriate methods in managing the patient's disease and complications that may stem from the primary disease. Liver/ spleen scintigraphic imaging can play a vital role in helping to piece together the sometimes complicated puzzle of portal
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY